Effect of ifetroban, a thromboxane A2 receptor antagonist, in stroke-prone spontaneously hypertensive rats

Clinical and Experimental Hypertension

Volumn 18, Issue 2, 1996, Pages 171-188

  Johnson, Robert A ^a   Belmonte, Augusta ^a   Fan, Newton Y T ^a   Lavesa, Manuel ^a   Nasjletti, Alberto ^a   Stier Jr , Charles T ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

blood pressure; stroke prone spontaneously hypertensive rats; thromboxane receptor antagonist ifetroban

Indexed keywords

IFETROBAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; TELEMETRY;

EID: 0029947231     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969609081763     Document Type: Article

References (29)

1. Nagaoka A, Iwatsuka H, Suzuoki Z, Okamoto K. Genetic predisposition to stroke in spontaneously hypertensive rats. Am J Physiol. 1976;230:1354-1359.
2. Yamori Y, Horie R, Handa H, Sato M, Fukase M. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke. 1976;7:46-53.
3. 2 in responses of cerebral arterioles during chronic hypertension. Am J Physiol. 1992;262:H539-H543.
4. 2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion. J Cardiovasc Pharmacol. 1988;12:701-709.
5. 2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats. Stroke. 1988;19:1145-1150.
6. Nagaoka A, Kakihana M, Iwatsuka H. Effects of prostaglandin inhibitors on the onset of proteinuria and stroke in stroke-prone spontaneously hypertensive rats. Japan J Pharmacol. 1981;31:125-127.
7. Gryglewski RJ, Nowak S, Kostka-Trabka E, Kusmiderski J, Dembinska-Kiec A, Bieron K, Basista M, Blaszczyk B. Treatment of ischaemic stroke with prostacyclin. Stroke. 1983;14:197-202.
8. 2 production in healthy subjects. Thromb Res. 1980;17:317-327.
9. 2 and prostacyclin. Stroke. 1992;23:1400-1403.
10. The SALT Collaborative Group: Swedish aspirin low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet. 1991;338:1345-1349.
11. Gent M. Single studies and overview analyses: is aspirin of value in cerebral ischemia? Stroke. 1987;18:541-544.
12. Misra RN, Brown BR, Sher PM, Patel MM, Hall SE, Man W-C, Barrish JC, Floyd DM, Sprague PW, Morrison RA, Ridgewell RE, White RE, DiDonato GC, Harris DN, Hedberg A, Schumacher W, Webb ML, Ogletree ML. Thromboxane receptor antagonist BMS-180,291: A new pre-clinical lead. Bioorg Med Chem Letters 1992;2:73-76.
13. Schumacher WA, Steinbacher TE, Youssef S, Ogletree ML. Antiplatelet activity of the long-acting thromboxane receptor antagonist BMS 180.291 in monkeys. Prostaglandins. 1992;44:389-397.
14. 2/prostaglandin endoperoxide receptor antagonist. J Pharmacol Exp Ther. 1993;264:570-578.
15. Misra RN, White RE, Ogletree ML. Ifetroban sodium. Drugs of the future 1994, 19:107-110.
16. 2 receptor antagonist BMS-180291 reduces the severity of pacing-induced ischemia in dogs. J Cardiovasc Pharmacol. 1994;24:493-499.
17. Gomoll AW, Grover GJ, Ogletree ML. Myocardial salvage efficacy of the thromboxane receptor antagonist, BMS-180291, in the ferret and dog. J Cardiovasc Pharmacol. 1994;24:960-968.
18. Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res. 1974;34 and 35 (Suppl I):I-143-I-153.
19. Brockway BP, Mills PA, Azar SH. A new method for continuous chronic measurement and recording of blood pressure, heart rate and activity in the rat via radio-telemetry. Clin Exp Hypertens. 1991;A13:885-895.
20. Bazil MK, Krulan C, Webb RL. Telemetric monitoring of cardiovascular paramenters in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1993;22:897-905.
21. Stier CT Jr, Benter IF, Ahmad S, Zuo H, Selig N, Roethel S, Levine S, Itskovitz HD. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension. 1989;13:115-121.
22. Yamori Y, Horie R, Tanase H, Fujiwara K, Nara Y, Lovenberg W. Possible role of nutritional factors in the incidence of cerebral lesions in stroke-prone spontaneously hypertensive rats. Hypertension. 1984;6:49-53.
23. Mistry M, Nasjletti A. Role of pressor prostanoids in rats with angiotensin-II salt-induced hypertension. Hypertension. 1988;11:758-762.
24. Testfamariam B, Ogletree M. Dissociation of endothelial cell dysfunction and blood pressure of SHR. Am J Physiol. 1995;269:H189-H194.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
26. Lee ET. Nonparametric methods for comparing survival distributions. In: Statistical Methods for Survival Data Analysis. Belmont: Wadsworth Inc., 1980;122-129.
27. Lin L, Mistry M, Stier CT Jr, Nasjletti A. Role of prostanoids in renin-dependent and renin-independent hypertension. Hypertension. 1991;17:517-525.
28. 2 in the hypotensive effect of captopril in essential hypertension. Hypertension. 1988;11:147-152.
29. 2 receptor antagonism and synthase inhibition in essential hypertension. Hypertension. 1993;22:197-203.